Log in

The adipogenic effect of palmitate in mouse bone marrow-derived mesenchymal stem cells

  • Original Article
  • Published:
Tissue Engineering and Regenerative Medicine Aims and scope

Abstract

In the present study, we examined the effect of palmitate on adipocyte differentiation in mouse bone marrow-derived mesenchymal stem cells (MSCs). Obesity is associated with increased adipocyte differentiation of preadipocytes or MSCs. Free fatty acids (FFAs) have been reported to have an influence on adipogenesis. Thus, the elevated level of FFAs in obese individuals may set off a vicious cycle of events leading to further increased adipogenesis. Palmitate is one of the most abundant FFAs in plasma. The results in this study showed that treatment with palmitate for 3 days, followed by maintenance with insulin for 4 days (palmitate 3d/insulin 4d), induced lipid accumulation and adipocyte protein 2 (aP2) expression in bone marrow-derived MSCs. Our results also showed that treatment with palmitate 3d/insulin 4d induced expressions of adipogenic transcription factors, namely CCAAT enhancer-binding protein (C/EBP) β, C/EBPα, and PPARΓ in bone marrow-derived MSCs. In comparison of palmitate with stearate, the levels of lipid accumulation, aP2, and adipogenic transcription factors in cells treated with palmitate 3d/insulin 4d were generally higher than those of cells treated with same concentration of stearate 3d/insulin 4d. Taken together, our results suggest that palmitate is a potent adipogenic FFA that triggers adipocyte differentiation of bone marrow-derived MSCs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. KM Flegal, MD Carroll, CL Ogden, et al., Prevalence and trends in obesity among US adults, 1999–2008, JAMA, 303, 235 (2010).

    Article  PubMed  CAS  Google Scholar 

  2. PG Kopelman, Obesity as a medical problem, Nature, 404, 635 (2000).

    PubMed  CAS  Google Scholar 

  3. E Manickam, AJ Sinclair, D Cameron-Smith, Suppressive actions of eicosapentaenoic acid on lipid droplet formation in 3T3-L1 adipocytes, Lipids Health Dis, 9, 57 (2010).

    Article  PubMed  Google Scholar 

  4. W Guo, S Wong, W **e, et al., Palmitate modulates intracellular signaling, induces endoplasmic reticulum stress, and causes apoptosis in mouse 3T3-L1 and rat primary preadipocytes, Am J Physiol Endocrinol Metab, 293, E576 (2007).

    Article  PubMed  CAS  Google Scholar 

  5. JT Crossno, Jr., SM Majka, T Grazia, et al., Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells, J Clin Invest, 116, 3220 (2006).

    Article  PubMed  CAS  Google Scholar 

  6. A Alhadlaq, M Tang, JJ Mao, Engineered adipose tissue from human mesenchymal stem cells maintains predefined shape and dimension: implications in soft tissue augmentation and reconstruction, Tissue Eng, 11, 556 (2005).

    Article  PubMed  CAS  Google Scholar 

  7. M Vallee, JF Cote, J Fradette, Adipose-tissue engineering: taking advantage of the properties of human adipose-derived stem/stromal cells, Pathol Biol (Paris), 57, 309 (2009).

    Article  CAS  Google Scholar 

  8. Commision on biochemical nomenclature, the nomenclature of lipids, Eur J Biochem, 79, 11 (1977).

  9. SW Coppack, MD Jensen, JM Miles, In vivo regulation of lipolysis in humans, J Lipid Res, 35, 177 (1994).

    PubMed  CAS  Google Scholar 

  10. G Boden, GI Shulman, Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction, Eur J Clin Invest, 32Suppl 3, 14 (2002).

    Article  PubMed  CAS  Google Scholar 

  11. HO Steinberg, M Tarshoby, R Monestel, et al., Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation, J Clin Invest, 100, 1230 (1997).

    Article  PubMed  CAS  Google Scholar 

  12. YH Hong, Y Nishimura, D Hishikawa, et al., Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43, Endocrinology, 146, 5092 (2005).

    Article  PubMed  CAS  Google Scholar 

  13. JY Yang, MA Della-Fera, S Rayalam, et al., Regulation of adipogenesis by medium-chain fatty acids in the absence of hormonal cocktail, J Nutr Biochem, 20, 537 (2009).

    Article  PubMed  CAS  Google Scholar 

  14. SW Qian, X Li, YY Zhang, et al., Characterization of adipocyte differentiation from human mesenchymal stem cells in bone marrow, BMC Dev Biol, 10, 47 (2010).

    Article  PubMed  CAS  Google Scholar 

  15. GM Reaven, C Hollenbeck, CY Jeng, et al., Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM, Diabetes, 37, 1020 (1988).

    Article  PubMed  CAS  Google Scholar 

  16. GV Richieri, AM Kleinfeld, Unbound free fatty acid levels in human serum, J Lipid Res, 36, 229 (1995).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Seong-Beom Lee or Gue-Tae Chae.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Park, E.Y., Yeum, C.E., Seo, G. et al. The adipogenic effect of palmitate in mouse bone marrow-derived mesenchymal stem cells. Tissue Eng Regen Med 10, 77–85 (2013). https://doi.org/10.1007/s13770-013-0005-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13770-013-0005-4

Key words

Navigation